Mehrotra Parth 4
4 · Privia Health Group, Inc. · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
Privia Health (PRVA) CEO Parth Mehrotra Sells Shares
What Happened Parth Mehrotra, CEO of Privia Health Group, sold a total of 63,439 shares between March 6 and March 9, 2026 for an aggregate proceeds of approximately $1,456,240. Individual reported transactions:
- 21,440 shares on 2026-03-06 at $23.15 ($496,336)
- 21,915 shares on 2026-03-09 at a weighted $22.84 ($500,539)
- 1,219 shares on 2026-03-09 at a weighted $23.37 ($28,488)
- 18,865 shares on 2026-03-09 at a weighted $22.84 ($430,877)
These were sales (not purchases); sales are often routine (e.g., tax-withholding or pre-set plans) rather than an explicit bullish signal.
Key Details
- Dates/prices: Mar 6 (21,440 @ $23.15); Mar 9 (21,915 @ $22.84; 1,219 @ $23.37; 18,865 @ $22.84). Overall weighted avg ~ $22.95/share.
- Total shares sold: 63,439; total proceeds: ~$1,456,240.
- Shares owned after transaction: Not specified in the information provided.
- Footnotes: Some shares were sold to satisfy tax withholding on RSU vesting (sell-to-cover). Other sales were executed under a Rule 10b5-1 trading plan. Reported weighted-price ranges: $22.35–$23.34 and $23.35–$23.41; the filer can provide a full breakdown on request.
- Filing: Report filed March 10, 2026; timing appears consistent with normal Form 4 reporting windows.
Context These transactions include sell-to-cover activity related to restricted stock unit vesting and sales under a pre-established 10b5-1 plan. Such transactions are commonly administrative or tax-driven and do not necessarily reflect a change in the insider’s view of the company. If you want a full per-trade price breakdown or the insider’s post-sale holdings, the filer or the company can provide that information on request.
Insider Transaction Report
- Sale
Common Stock, $0.01 par value per share
[F1]2026-03-06$23.15/sh−21,440$496,336→ 385,794 total - Sale
Common Stock, $0.01 par value per share
[F2][F3]2026-03-09$22.84/sh−21,915$500,539→ 363,879 total - Sale
Common Stock, $0.01 par value per share
[F2][F4]2026-03-09$23.37/sh−1,219$28,488→ 362,660 total - Sale
Common Stock, $0.01 par value per share
[F1]2026-03-09$22.84/sh−18,865$430,877→ 343,795 total
Footnotes (4)
- [F1]The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.35 to $23.34 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.35 to $23.41 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.